Glucose-lowering treatment and clinical results in 163 121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register.
about
Risk Factors for Fatal Hyperglycaemia Confirmed by Forensic Postmortem Examination - A Nationwide Cohort in SwedenImpact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes.Effects of generic substitution on refill adherence to statin therapy: a nationwide population-based studyCost-utility analysis of glucagon-like Peptide-1 agonists compared with dipeptidyl peptidase-4 inhibitors or neutral protamine hagedorn Basal insulin as add-on to metformin in type 2 diabetes in swedenDurability of oral hypoglycemic agents in drug naïve patients with type 2 diabetes: report from the Swedish National Diabetes Register (NDR).Sex disparities in the quality of diabetes care: biological and cultural factors may play a different role for different outcomes: a cross-sectional observational study from the AMD Annals initiative.Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care.Refill adherence and persistence to lipid-lowering medicines in patients with type 2 diabetes: A nation-wide register-based study.Change in glycated haemoglobin levels after initiating second-line therapy in type 2 diabetes: a primary care database study.Distinct HbA1c trajectories in a type 2 diabetes cohort.Trends over 8 years in quality of diabetes care: results of the AMD Annals continuous quality improvement initiative.Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register.
P2860
Q28552857-C4221060-C4F7-4D44-B21B-EC4425521807Q33573537-BC506D6C-3037-4C95-A2F6-B6E03C81FA9EQ34694318-DC844834-06FE-4E18-B8B0-97095E6DEC6AQ34726534-BA7EF597-4A35-476A-A09B-0DE56287D7C7Q35203980-D6EFAE34-6EC8-4321-851D-793F1629BAA6Q37193449-F223BB72-D3E9-478B-BE7B-1DA8E7FE7B1BQ37561605-5EBC47C6-685C-45C6-BE8F-A960369CBA17Q37682234-D46BC2CC-4E71-4C82-952B-28DBE2EF6D1FQ38629283-3530C5D7-47E7-4D89-B944-D692C0824433Q40808660-40925AF9-0FC1-492B-BCD9-3CD9E0956B45Q43433493-C30837D6-EDFC-40E0-AB12-E153EA07E331Q51023486-C17C56E3-0F5F-4CBA-A2DD-918B418DBCE3Q54383946-FF2E5D76-E7E4-4E26-A5FD-31B14A32156B
P2860
Glucose-lowering treatment and clinical results in 163 121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Glucose-lowering treatment and ...... sh national diabetes register.
@en
Glucose-lowering treatment and ...... sh national diabetes register.
@nl
type
label
Glucose-lowering treatment and ...... sh national diabetes register.
@en
Glucose-lowering treatment and ...... sh national diabetes register.
@nl
prefLabel
Glucose-lowering treatment and ...... sh national diabetes register.
@en
Glucose-lowering treatment and ...... sh national diabetes register.
@nl
P2093
P2860
P921
P1476
Glucose-lowering treatment and ...... sh national diabetes register.
@en
P2093
A-M Svensson
B Eliasson
B Zethelius
J Cederholm
K Andersson Sundell
M Miftaraj
S Gudbjörnsdottir
P2860
P304
P356
10.1111/J.1463-1326.2012.01591.X
P577
2012-04-01T00:00:00Z